Cargando…
Oral cancer cells may rewire alternative metabolic pathways to survive from siRNA silencing of metabolic enzymes
BACKGROUND: Cancer cells may undergo metabolic adaptations that support their growth as well as drug resistance properties. The purpose of this study is to test if oral cancer cells can overcome the metabolic defects introduced by using small interfering RNA (siRNA) to knock down their expression of...
Autores principales: | Zhang, Min, Chai, Yang D, Brumbaugh, Jeffrey, Liu, Xiaojun, Rabii, Ramin, Feng, Sizhe, Misuno, Kaori, Messadi, Diana, Hu, Shen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972515/ https://www.ncbi.nlm.nih.gov/pubmed/24666435 http://dx.doi.org/10.1186/1471-2407-14-223 |
Ejemplares similares
-
Quantitative proteomic analysis of sphere-forming stem-like oral cancer cells
por: Misuno, Kaori, et al.
Publicado: (2013) -
Therapeutic siRNA silencing in inflammatory monocytes
por: Leuschner, Florian, et al.
Publicado: (2011) -
Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014) -
Metabolic rewiring in melanoma
por: Ratnikov, Boris I., et al.
Publicado: (2016) -
Nanocarriers for delivery of siRNA as gene silencing mediator
por: Morales-Becerril, Aideé, et al.
Publicado: (2022)